Skip to main content
SpringerLink
Log in

Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine-induced pruritus

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Twenty-one healthy Nigerian volunteers distributed into four groups participated in a study to determine the significance of chloroquine disposition in chloroquine-induced pruritus. It involved the administration of chloroquine with or without promethazine pre-adrninistration to the subjects. Group I consisted of 8 chloroquine non-hypersensitive subjects receiving 2 tablets of chloroquine sulphate (300 mg base); Group n consisted of 5 chloroquine non-hypersensitive subjects receiving 2 tablets of chloroquine sulphate 30 minutes after 25 mg promethazine tablet pre-administration; Group HI consisted of 5 chloroquine hypersensitive subjects treated as in Group H; Group IV consisted of 3 hypersensitive subjects treated as in Group I. Blood (5 ml) and urine samples were collected periodically for up to 6 days post-dose. The samples were analysed for chloroquine and some of its oxidation metabolites by a specific HPLC method. Probit plots of cumulative drug/metabolite ratios were done to determine if there is polymorphism in chloroquine metabolism.

There was bimodality only in the distribution of chloroquine/monodesethylchloroquine ratios, suggesting polymorphism in the metabolic oxidation of chloroquine in these subjects. Higher levels of monodesethylchloroquine were obtained in Group IV subjects when compared with any of the other groups. The oral clearance rate, elimination half-life, and volume distribution at steady state of chloroquine in the study groups were not significantly different (P > 0.05). In the absence of promethazine there appears to be an extensive metabolism of chloroquine in hypersensitive individuals to produce monodesethylchloroquine which probably determines the degree of pruritus experienced by an individual.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organisation (1984): Advances in malaria chemotherapy. WHO Tech. Rep. Ser., 711, 2–30.

    Google Scholar 

  2. Ekpechi OX., Okoro A.N. (1964): A pattern of pruritus due to chloroquine. Arch. Dermatol., 89, 631–632.

    Article  CAS  PubMed  Google Scholar 

  3. Olatunde I.A. (1977): The practical and therapeutic implications of chloroquine-induced itching in tropical Africa. Afr. J. Med. Sei., 6, 27–32.

    CAS  Google Scholar 

  4. Olatunde I.A. (1971): Chloroquine concentrations in skin of rabbits and man. Br. J. Pharmacol., 43, 335–340.

    CAS  PubMed  Google Scholar 

  5. Evans D.A.P., Fletcher K.S., Batty J.D. (1979): The urinary excretion of chloroquine in different ethnic groups. Ann. Trop. Med. Parasitol., 73, 11–17.

    CAS  PubMed  Google Scholar 

  6. Agrawal S.L., Deshmanka B.S. (1963): The in vitro antihistaminic and antianaphylactic actions of chloroquine. Arch. Int. Pharmacodyn. Ther., 143, 401–407.

    Google Scholar 

  7. Ayiteh-Smith E.A., Boye G.L. (1974): Effect of chloroquine on histamine-induced bronchial asthma in the guinea-pig. J. Pharm. Pharmacol., 26, 208–209.

    Google Scholar 

  8. Ciszek J., Walczak J. (1971): Treatment of asthma with chloroquine. Pol. Med. J., 10, 1125–1130.

    CAS  PubMed  Google Scholar 

  9. Kench J.G., Seale J J?, Temple D.M., Tramant C. (1985): The effects of non-steroidal inhibitors of phospholipase A2 on leukotriene and histamine release from human and guinea-pig lung. Prostaglandins, 30, 199–208.

    Article  CAS  PubMed  Google Scholar 

  10. Osifo N.G. (1983): Chloroquine pharmacokinetics in tissues of pyrogen treated rats and implications for chloroquine related pruritus. Res. Commun. Chem. Pathol. Pharmacol., 30, 419–430.

    Google Scholar 

  11. Jindal M.N. (1970): Adrenergic neurone blockade with chloroquine and amodiaquine. Indian J. Med. Res., 58, 1050–1056.

    CAS  PubMed  Google Scholar 

  12. McChesney E.W., Barts W.F. Jr., Sullivan DJ. (1965): Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats. Toxicol. Appl. Pharmacol., 7, 627–636.

    Article  CAS  PubMed  Google Scholar 

  13. Shaffer B., Cahn M M, Levy EJ. (1958): Absorption of antimalarial drugs in human skin. Spectroscopic and chemical analysis of epidermis and corium. J. Invest Dermatol., 30, 341–345.

    CAS  PubMed  Google Scholar 

  14. Ette E.I., Essien E.E. (1986): Neuromuscular weakness and ultrastructural damage produced by desethylated metabolites of chloroquine and the reversal by calcium. West Afr. J. Anat., 1, 5–15.

    Google Scholar 

  15. Essien E.E., Ette E.I. (1986): Effects of chloroquine and didesethylchloroquine on rabbit myocardium and mitochondria. J. Pharm. Pharmacol., 38, 833–840.

    Google Scholar 

  16. Essien E.E., Ifudu N.D. (1984): Residual chloroquine and metabolites in man as a sequel of previous chloroquine medications: a urinary excretion study and its significance. J. Trop. Med. Hyg., 87, 131–136.

    CAS  PubMed  Google Scholar 

  17. von Sallman L., Berstein H.M. (1963): Adverse effects of chloroquine and related antimalarial drugs on ocular structures. Bull. Rheum. Dis., 14, 327–330.

    Google Scholar 

  18. Gibaldi M., Perrier D. (1982): Pharmacokinetics. 2nd edn. New York: Marcel Dekker

    Google Scholar 

  19. Gustafsson L.L., Walker O., Gunner A. et al. (1983): Disposition of chloroquine in man after single intravenous and oral doses. Br. J. Clin. Pharmacol., 15, 471–477.

    CAS  PubMed  Google Scholar 

  20. Documenta Geigy (1975): Scientific Tables, 7th edn. Diem, K., Lentner, C. eds. Macclesfield, U.K. Geigy Pharmaceuticals.

    Google Scholar 

  21. McManus L.M. (1985): Phospholipids may hold key to allergic and immunologic reactions. Clin. Pharm., 4, 245–248.

    Google Scholar 

  22. Kalow W. (1982): The metabolism of xenobiotics in different populations. Can. J. Physiol. Pharmacol., 60, 1–12.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, College of Medicine of the University of Lagos, Idi-Araba, Lagos, Nigeria

    E. E. Essien

  2. Department of Clinical Pharmacy and Biopharmacy, School of Pharmacy, College of Medicine of the University of Lagos, Lagos, Nigeria

    E. E. Essien

Authors
  1. E. E. Essien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. I. Ette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. O. A. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. A. Brown-Awala
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Essien, E.E., Ette, E.I., Thomas, W.O.A. et al. Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine-induced pruritus. Eur. J. Drug Metab. Pharmacokinet. 14, 71–77 (1989). https://doi.org/10.1007/BF03190844

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190844

Keywords

Search

Navigation